ClinicalTrials.gg
CompletedNCT07431671FEEDINGUpdated Nov 6, 2026

Feeding Disorders in Children

An interventional study of Interdisciplinary intervention and Standard rehabilitation program in Neurodevelopmental Disorder (Diagnosis), Feeding Disorder and ARFID, sponsored by IRCCS San Raffaele Roma. Completed at 1 site in Italy. Open to participants aged 2 Years to 7 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by IRCCS San Raffaele Roma · Not applicable, Interventional, and Treatment

How we know

Updated Nov 6, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
2 Years to 7 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 35 studies in Neurodevelopmental Disorders with a site in Italy — 18 open to participants now, 24 under way, 6 of them phase 3. Neurodevelopmental Disorders · Italy.

Enrollment
23rd of 25
24 · median 80
Started
2026
with 2 others
No phase
18 of 35
9 open now
Registered
31st of 35
by date

Among the 35 studies in Neurodevelopmental Disorders with a site in Italy, this one is the 23rd largest by enrollment of the 25 interventional ones that give a count, is one of 3 that started in 2026, is one of 18 with no phase, and was the 31st registered.

Neurodevelopmental Disorders

355 studies on the registry are indexed under Neurodevelopmental Disorders; 144 are open to participants now.

Browse Neurodevelopmental Disorders studies →

Open to participants now

18 of the 35 studies in Neurodevelopmental Disorders with a site in Italy are open now. Recruiting first, the newest first:

13 more — sign in →

All 18 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 100 Neurodevelopmental Disorders studies recruiting now, 20 (20%) set no upper age limit and 76 (76%) stop at 75 or younger; 86 take children under 18; 31 take healthy volunteers.

This study: 2 Years to 7 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 35 studies in Neurodevelopmental Disorders with a site in Italy, or all of them as a file.
02

Study summary

Pediatric Feeding Disorders (PFDs) are conditions characterized by persistent difficulties in food intake, commonly manifesting as food selectivity, food refusal, and dysfunctional mealtime behaviors. Their prevalence in the general pediatric population ranges from 3% to 10%, with substantially higher rates reported among children with neurodevelopmental disorders. The impact of PFDs extends beyond growth and nutritional status, affecting cognitive and emotional development as well as the well-being of the entire family system. Although several treatment models have been proposed, scientific evidence supporting outpatient interventions remains limited and Italy-specific studies are lacking. Moreover, despite the availability of standardized assessment tools, feeding-related outcomes are not yet systematically addressed within outpatient clinical practice for children with neurodevelopmental disorders.

The present study aims to evaluate whether an interdisciplinary intervention protocol involving a psychologist, a speech and language therapist (SLP), and a Neuro and Psychomotor Therapist of Developmental Age (TNPEE) can improve food variety and reduce dysfunctional mealtime behaviors in this population. The study is designed as a pilot randomized controlled trial developed across five sequential phases: participant enrollment and screening using the Montreal Children's Hospital Feeding Scale (MCH-FS); baseline standardized assessment (T0) using the Pediatric Eating Assessment Tool (PediEAT) and the Short Sensory Profile (SSP); random allocation of participants to an experimental group or a control group; delivery of the interdisciplinary intervention exclusively to the experimental group; and a final standardized assessment conducted six weeks later (T1) to evaluate changes over time and between groups.

This pilot study primarily aims to assess feasibility and to estimate the variability of outcome measures; therefore, no formal sample size or power calculation was performed. The planned enrollment of 12 participants per group was determined based on feasibility considerations and in line with CONSORT recommendations for pilot trials. The proposed protocol seeks to address current gaps in the literature by systematically targeting feeding-related outcomes through an explicitly interdisciplinary approach that integrates psychological, speech and language, and neuropsychomotor perspectives in the management of PFD.

03

Conditions studied

04

Who can participate

Ages eligible
2 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 2 and 7 years.
  • Diagnosis of a neurodevelopmental disorder according to criteria.
  • Presence of a feeding disorder.

Exclusion criteria

Exclusion Criteria:

  • Presence of respiratory, cardiovascular, gastrointestinal, or neurological conditions preventing oral feeding.
  • Insufficient caregiver proficiency in the Italian language, such as to compromise completion of the questionnaires.
  • Children who are undergoing a different feeding intervention at the time of screening.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Interdisciplinary Feeding Intervention

    Other: Interdisciplinary intervention

  • Active comparator
    Standard Rehabilitation

    Other: Standard rehabilitation program

Interventions

  • OtherInterdisciplinary intervention

    Each patient undergoes 12 individual therapy sessions (twice weekly over 6 consecutive weeks), each lasting 45 minutes. Sessions are conducted by a psychologist, who provides parent training, and by a speech-language pathologist (SLP) and a Neuro and Psychomotor Therapist of Developmental Age (TNPEE), who deliver direct intervention to the child in the presence of the caregiver. The psychologist establishes a feeding routine and educates the caregiver on emotional and behavioral management during mealtimes. The SLP and TNPEE implement play-based sensory activities and a specific exercise protocol to enhance oral sensitivity and strengthen orofacial musculature. From the second session onward, the food diary is monitored and caregivers receive guidance for the gradual introduction of new foods at home. At each session, the interdisciplinary team monitors progress based on food diary data and caregiver reports and adapts the intervention to the child's needs.

  • OtherStandard rehabilitation program

    Participants in the control group receive standard multidisciplinary rehabilitation as provided in an ex art. 26 accredited rehabilitation center. The rehabilitation program includes speech and language therapy, neuro and psychomotor therapy (TNPEE), physiotherapy, and psychological support, delivered according to an individualized rehabilitation plan. Treatments are provided by licensed therapists in accordance with routine clinical practice.The frequency and duration of each intervention are defined by the individualized rehabilitation plan and reflect standard clinical practice.

06

What researchers measure

Primary outcomes

  1. Pediatric Eating Assessment Tool (PediEAT) Total Score

    The Pediatric Eating Assessment Tool (PediEAT) is a standardized parent-report questionnaire consisting of 78 items assessing observable feeding-related symptoms in children aged 6 months to 7 years. Each item is rated on a 6-point Likert scale (0 to 5). The total score ranges from 0 to 390, with higher scores indicating greater feeding-related concern (worse outcome).

    Time frame: Baseline and immediately post-intervention (6 weeks)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Sep 2026, 8 months.

Of 142 non-industry interventional studies with no phase under Neurodevelopmental Disorders, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 52. This study's 8 months is below that.

Counting every sponsor, half of 148 studies reached it within 30 months; a quarter within 15 and three quarters within 52.

Primary completion moved twice since we started tracking on Sep 25, 2026: Feb 2026 → Sep 2026, last on Nov 6, 2026.

Completion moved twice since we started tracking on Sep 25, 2026: Feb 2026 → Oct 2026, last on Nov 6, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2026
First posted
Feb 24, 2026
StartActual
Jan 1, 2026
Primary completionActual
Sep 30, 2026was Feb 2026
CompletionActual
Oct 1, 2026was Feb 2026
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 6, 2026
Primary completion
Feb 20, 2026→Sep 30, 2026 (actual)
moved 2 times, Oct 16, 2026 – Nov 6, 2026
Study completion
Feb 28, 2026→Oct 1, 2026 (actual)
moved 2 times, Oct 16, 2026 – Nov 6, 2026
Show all 2 updates
  1. Nov 6, 2026
    Recruiting→Completed
    Primary completion Dec 2026→Sep 30, 2026 (now actual)
    Study completion Dec 28, 2026→Oct 1, 2026 (now actual)
    + 4 other changes: verification date, arm descriptions, contact details and site details
  2. Oct 16, 2026
    Primary completion Feb 20, 2026→Dec 2026
    Study completion Feb 28, 2026→Dec 28, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07431671
Lead sponsor
IRCCS San Raffaele Roma
Responsible party
Sponsor
First posted
Feb 24, 2026
Start date
Jan 1, 2026
Primary completion
Sep 30, 2026
Completion
Oct 1, 2026
Last update
Nov 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion